The purpose of this study is to determine the acceptance and efficacy of the online self-help program deprexis® for depressed patients in reducing the clinical symptoms of their depression. The patients of the experimental group use deprexis® for 90 days, the patients of the placebo group receive weekly online information about depression for 90 days as well. Both groups receive their treatment in addition to their regular inpatient psychosomatic treatment and as an aftercare intervention.The investigators hypothesize that the online self-help group achieves a greater reduction of depression compared to the control group.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
229
Online self-help program in addition to inpatient psychosomatic treatment for 90 days.
The patients receive online information about depression once a week for 90 days.
Psychosomatic Clinic Bad Neustadt
Bad Neustadt an der Saale, Bavaria, Germany
University Medical Center, Department of Psychosomatic Medicine and Psychotherapy, Johannes Gutenberg University
Mainz, Rhineland-Palatinate, Germany
Reduction of depression measured with the "Beck's Depression Inventory" (BDI-II)
Time frame: Three months after randomization
Reduction of depression measured with the depression scale of the "Patient Health Questionnaire" (PHQ-9)
Time frame: Randomization, end of inpatient treatment (average 6 weeks), six months after randomization
Reduction of depression measured with the "Beck's Depression Inventory" (BDI-II)
Time frame: Randomization, end of inpatient treatment (average 6 weeks), six months after randomization
Reduction of anxiety measured with the "Generalized Anxiety Disorder Scale" (GAD-7)
Time frame: Randomization, end of inpatient treatment (average 6 weeks), six months after randomization
Reduction of dysfunctional depression related cognitions measured with the "Dysfunctional Attitude Scale" (DAS)
Time frame: Randomization, end of inpatient treatment (average 6 weeks), six months after randomization
Improved self-esteem measured with the "Rosenberg Self-Esteem Scale" (RSE)
Time frame: Randomization, end of inpatient treatment (average 6 weeks), six months after randomization
Improved quality of life measured with the "European Health Interview Survey Quality of Life-8" (EUROHIS-QOL 8)
Time frame: Randomization, end of inpatient treatment (average 6 weeks), six months after randomization
Improved working ability measured with the short form of the "Work Ability Index" (WAI)
Time frame: Randomization, end of inpatient treatment (average 6 weeks), six months after randomization
Acceptance and utilization of deprexis® measured with a self devised questionnaire
Time frame: End of inpatient treatment (average 6 weeks), three months after randomization
Acceptance and utilization of the information used in the placebo condition measured with a self devised questionnaire
Time frame: End of inpatient treatment (average 6 weeks), three months after randomization
Degree of childhood traumas measured with the "Childhood Trauma Questionnaire" (CTQ)
Assumption that childhood traumas, assessed at the beginning of treatment, have a moderating effect on the reduction in the primary outcome measure.
Time frame: Randomization
Degree of structural deficits measured with the short form of the OPD-Structure Questionnaire (OPD-SFK)
Assumption that structural deficits, as assessed with the OPD-SFK questionnaire at the beginning of treatment have a moderating effect on the reduction in the primary outcome measure.
Time frame: Randomization
Therapeutic alliance between participant and inpatient psychotherapist measured with the "Helping Alliance Questionnaire" (HAQ).
Time frame: Randomization, end of inpatient treatment (average 6 weeks)
Course of mood, depressiveness and utilization of units
Time frame: During inpatient treatment (average 6 weeks)
Utilization of other treatments after the end of inpatient treatment
Time frame: Six months after randomization
Satisfaction with inpatient treatment
Time frame: End of inpatient treatment (average 6 weeks)
Willingness to pay
Time frame: Three months after randomization
Remission from depression
BDI score below the cutoff of 13 and a reliable change regarding Reliable Change Index (RCI)
Time frame: End of inpatient treatment (average 6 weeks), three months after randomization, six months after randomization
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.